MEDISUPPLY
ActiveThe computed 12-month bankruptcy probability of MEDISUPPLY is 4.6% (elevated). The 2025 annual accounts show equity of €7k and a net result of €-1k. Its solvency ranks better than 36% of 17987 sector peers (fiscal year 2025). The company has been active since 2024 and the Belgian State Gazette contains no insolvency or warning signals.
Checked score
Score 2025
Axes · tick = 2024
Profitability0=
Solvency29▼-71
Growth58
Stability82
Bankruptcy probability, 12 months
4.6%
Elevated
0%0.5%1.5%4%10%≥ 25%
Credit up to €500 at 30 days only on tighter terms
Liquidity tight (current ratio 1.24), and 81.7% of the assets are financed with debt.
Credit advice for your own amount and term
Signals
Eight signals. The signal on the left, the evidence on the right.
+raises risk○neutral
raises risk · Young company
A young company has little track record yet and statistically fails more often than an established one.
KBO · incorporation dateAge against the risk zone
raises risk · Higher-failure-rate sector
In this sector companies fail more often than the Belgian average.
Gazette · bankruptcies per sector, NACE 47
Relative position
BE, all sectors
reference
Sector 47
higher
← fewer bankruptcies
more bankruptcies →
raises risk · Annual accounts: weaker financial profile
The latest annual accounts show a weaker profile in solvency, result or liquidity than companies that stay afloat.
NBB · annual accounts 2025Solvency, return and age of the figures
Solvency
18.3%
Return on assets
-3.5%
Age of the figures
8 mo
raises risk · Persistent losses
Two consecutive loss-making years (2024 and 2025); equity fell accordingly. May indicate structural pressure on profitability.
NBB · annual accounts 2025Net result per financial year
2425
2024 to 2025 · latest year -€1k
neutral · Filed after the deadline
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 27-08-2026, 27 days later. For context: 47% of the Belgian market files late and the whole 1-to-90-day band measures 2.0% abnormal legal state against a 1.66% average. We show this as a fact and do not score it.
NBB · 2 filingsDeviation from the deadline
2025
27 d late
2024
29 d late
← before the deadline
after the deadline →
neutral · The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today.
Companies Code · seven monthsPosition in the running window
14-09-2026 today31-12-2026 close31-07-2027 deadline
Financials · fiscal year 2025, micro schema
Equity
€7k▼ 16.0%
2024 · €8k
2024: €8k
2024 → 2025
Total assets
€37k▲ 333%
2024 · €8k
2024: €8k
2024 → 2025
Net result
€-1k▲ 68.6%
2024 · €-4k
2024: €-4k
2024 → 2025
Working capital
€7k
Multi-year overview
Every figure with its change against the year before
▲ rise
▼ fall
Line20242025Trend
Equity€8k-€7k▼ 16.0%
Operating result€-4k-€16
Net result€-4k-€-1k▲ 68.6%
Turnover and EBIT margin not published: the micro schema does not require them.
Result per fiscal year
Operating resultNet result
The operating result returns to profit in 2025: €16 after a loss of €4k in 2024.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Equity and liabilities €37k
Equity
€7k▼ 16.0%
Debt
€30k▲ 5,875%
The debt ratio rises from 5.9% to 81.7%: debt grows while equity shrinks.
Key figures and ratios
Solvency
18.3%▼
2024 · 94.1%
Current ratio
1.24
Quick ratio
0.67
Debt / equity
4.48▲
2024 · 0.06
ROE
-19.1%▲
2024 · -51.1%
ROA
-3.5%▲
2024 · -48.0%
Debt
€30k▲
2024 · €500
Debt ≤ 1 year
€29k
Green means a favourable move, even when the figure itself falls: as with debt or debt / equity.
Filed annual accounts
As filed with the NBB · 2025 against 2024
Balance sheet
Code20242025
Assets
Total assets20/58€8k€37k▲
Current assets29/58€8k€37k▲
Stocks and contracts in progress3€5k€17k▲
Stocks30/36€5k€17k▲
Amounts receivable within one year40/41€374€7k▲
Trade receivables40€175€6k▲
Other amounts receivable41€199€1k▲
Cash at bank and in hand54/58€3k€13k▲
Equity and liabilities
Total equity and liabilities10/49€8k€37k▲
Equity10/15€8k€7k▼
Contributions10/11€12k€12k=
Profit (loss) carried forward14€-4k€-5k▼
Amounts payable17/49€500€30k▲
Amounts payable within one year42/48-€29k
Trade debts44-€298
Suppliers440/4-€298
Other amounts payable47/48-€29k
Accrued charges and deferred income492/3€500€500=
Income statement
Code20242025
Other operating charges640/8€387€3k▲
Gross operating margin9900€-4k€3k▲
Operating profit (loss)9901€-4k€16▲
Financial charges65/66B€29€1k▲
Recurring financial charges65€29€1k▲
Profit (loss) for the period before taxes9903€-4k€-1k▲
Profit (loss) for the period9904€-4k€-1k▲
Profit (loss) for the period to be appropriated9905€-4k€-1k▲
Appropriation of the result
Profit (loss) to be appropriated9906€-4k€-5k▼
Profit (loss) brought forward from the previous period14P-€-4k
The notes to these accounts (1 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.
Timeline · acts, filings and financial milestones
Next filing, fiscal year 2026, expected by
2026
27-08
NBB filing
Annual accounts filed
fiscal year 2025 · micro schema · 27 days late
2025
29-08
NBB filing
Annual accounts filed
fiscal year 2024 · micro schema · 29 days late
NBB filing
Directors · office · real estate
Directors
1 act for this company is in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Ukkel · 1 establishment unit since 2024
Cannot be placed on the map
This address could not be matched to a point in the Belgian address register (BOSA BEST). The address below comes straight from the Crossroads Bank.
Stillelaan 281180 UkkelGround area
144 m²
Building footprint
88 m²
Volume, LiDAR
594 m³
Parcel 21614F0083/00P009, Brussels · tallest building 11.2 m, ±3 floors. Linked by address, not a title deed.
1 establishment unit
DENTAL MARKET
since 20242.361.134.309
1 parcel
Brussels
1
(100%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 21614F0083/00P009 | Brussels | 144 m² | 1 · 88 m² | 11.2 m · 3 fl. |
Linked by address, not proof of ownership
Methodology
via registered seat: 1
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Similar companies · same sector, comparable size
ANNE DEVILLERS
BE 1011.983.182
Seraing · Eq €7k
Jolien Desmet
BE 0741.619.537
Antwerpen · Eq €7k
ewimed Belgium
BE 1008.273.131
Gent · Eq €7k
BodyReal prosthetics
BE 0744.552.994
Brugge · Eq €7k
INFIX'MEDICAL
BE 0758.834.562
Lobbes · Eq €7k
Of 1,063 companies in sector 47741 we hold annual accounts for 639. 198 are within a factor 10 of this equity.See the whole sector
Company data · Crossroads Bank
Identification
Legal formPrivate limited company
Founded18-06-2024
Fiscal year end31-12
Activities, NACEBEL
47740Retail trade
47741Retail sale of medical and orthopaedic goods, excluding prescription glasses and lenses
Sources
Crossroads Bank for EnterprisesNational Bank · 2 filingsAddress and cadastre registers
Data from official sources, last processed on 13-09-2026. Scores and ratios are computed by Checked and are not a credit decision.